IRIS
RIPA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.665
NA - Nord America 1.537
EU - Europa 1.056
SA - Sud America 369
AF - Africa 47
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.435
SG - Singapore 595
CN - Cina 515
IT - Italia 295
SE - Svezia 294
BR - Brasile 289
HK - Hong Kong 263
DE - Germania 116
VN - Vietnam 96
GB - Regno Unito 74
RU - Federazione Russa 69
CA - Canada 66
IN - India 43
FI - Finlandia 41
AR - Argentina 34
PL - Polonia 34
AT - Austria 30
JP - Giappone 29
AU - Australia 28
MX - Messico 25
NL - Olanda 22
FR - Francia 21
ZA - Sudafrica 17
ES - Italia 16
PK - Pakistan 15
BD - Bangladesh 14
IR - Iran 12
TR - Turchia 12
EC - Ecuador 10
ID - Indonesia 10
CO - Colombia 9
TN - Tunisia 9
UA - Ucraina 9
BE - Belgio 8
CL - Cile 8
IQ - Iraq 7
KR - Corea 7
MA - Marocco 7
VE - Venezuela 7
EG - Egitto 6
IE - Irlanda 6
PH - Filippine 6
PY - Paraguay 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
PT - Portogallo 5
UY - Uruguay 5
HR - Croazia 4
CH - Svizzera 3
CY - Cipro 3
IL - Israele 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
TW - Taiwan 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
NI - Nicaragua 2
PA - Panama 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
KE - Kenya 1
KZ - Kazakistan 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.703
Salva come PNG Salva come JPEG
Città #
Singapore 324
Hong Kong 261
Dallas 223
Ashburn 197
Beijing 124
New York 121
Shanghai 118
Hefei 78
Los Angeles 64
Milan 62
Lawrence 60
Princeton 59
Boardman 47
Munich 38
São Paulo 37
Ho Chi Minh City 34
Montreal 29
Warsaw 29
Denver 28
Helsinki 25
Tokyo 25
Moscow 23
Nuremberg 21
Cesano Boscone 20
Hanoi 20
Chennai 19
Poplar 19
Orem 18
Rome 18
Seattle 18
Genoa 17
Stockholm 17
Atlanta 16
Houston 16
Brooklyn 15
Santa Clara 15
Toronto 15
London 14
Turku 13
Mexico City 12
Guangzhou 11
Johannesburg 11
Rio de Janeiro 11
Washington 11
Wollongong 10
Boston 9
Falkenstein 9
Lahore 9
Tianjin 9
Brisbane 8
Chicago 8
Huskvarna 8
Manchester 8
San Francisco 8
The Dalles 8
Turin 8
Verona 8
Vienna 8
Amsterdam 7
Ankara 7
Belo Horizonte 7
Columbus 7
Curitiba 7
Phoenix 7
Brasília 6
Brussels 6
Da Nang 6
Frankfurt am Main 6
Melbourne 6
Naples 6
Tashkent 6
Caruaru 5
Catania 5
Kassel 5
Montevideo 5
Mumbai 5
Padova 5
Pune 5
Querétaro 5
Vancouver 5
Vittoria 5
Yongin-si 5
Assago 4
Baghdad 4
Buenos Aires 4
Fremont 4
Quezon City 4
Santo André 4
Thetford 4
Uberlândia 4
Zagreb 4
Amman 3
Angera 3
Asunción 3
Ballincollig 3
Bogotá 3
Borås 3
Cairo 3
Calgary 3
Caracas 3
Totale 2.673
Salva come PNG Salva come JPEG
Nome #
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 180
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 133
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 109
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 109
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 107
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 98
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 94
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 90
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 88
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 87
Biobanking for COVID-19 research 86
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 79
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 79
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 76
Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci 75
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 74
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 73
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 72
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 72
Ceftobiprole for the treatment of infective endocarditis: A case series 72
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 71
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 70
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study 69
Subclinical myocardial dysfunction in patients recovered from COVID-19 68
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry 67
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 66
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 65
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study 65
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 65
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 65
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 64
Beneficial effects of cART initiated during primary and chronic HIV-1 infection on immunoglobulin-expression of memory B-cell subsets 63
Role of Rehabilitation Department for Adult Individuals With COVID-19: The Experience of the San Raffaele Hospital of Milan 63
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 62
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19 62
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes 61
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 59
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patients 58
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 58
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 58
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report 53
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 53
Bowel perforation in a Covid-19 patient: case report 52
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 51
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 51
How do I manage a patient with Stenotrophomonas maltophilia infection? 49
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis 49
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience 48
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen 47
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 46
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 46
Dynamics of adaptive and innate immunity inpatients treated during primary human immunodeficiency virus infection: Results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial 45
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 44
Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine 44
Short-term peripheral venous catheter-related bloodstream infections: Evidence for increasing prevalence of Gram-negative microorganisms from a 25-year prospective observational study 44
Maraviroc 150mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study 44
Immunosenescence and hurdles in the clinical management of older HIV-patients 43
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 42
Estimated glomerular filtration rate trajectories in HIV-infected subjects treated with different ritonavir-boosted protease inhibitors and tenofovir disoproxil fumarate or abacavir 41
Eosinophils from Physiology to Disease: A Comprehensive Review 40
Comprehensive CT study to assess local and systemic involvement in patients with infective endocarditis: experience from a multidisciplinary team of a tertiary referral center 39
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study) 39
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up 39
Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient 39
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa 38
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis-authors' response 38
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients 37
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection 37
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 37
Rugarli. Medicina interna sistematica 36
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 35
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study 35
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART 34
Immunological Recovery After 24 Weeks of Antiretroviral Therapy in Patients With X4 Virus During Primary HIV Infection 33
Is shorter duration of antibiotic treatment feasible in patients with cardiac implantable electronic device infections undergoing device removal? A propensity-adjusted analysis of a 10-year retrospective cohort 33
Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis 32
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response 31
Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature 28
Rugarli. Medicina interna sistematica 27
Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy 20
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections 13
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 7
Bridging the gap in bloodstream infection management: A survey among non-infectious disease physicians 6
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research 2
Totale 4.874
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 12 1 10 1 0 2 0
2021/2022151 1 0 3 31 13 15 16 13 10 6 7 36
2022/2023482 136 113 22 9 20 63 16 52 14 10 17 10
2023/2024519 17 45 92 37 52 111 11 49 5 17 24 59
2024/20251.433 116 39 41 71 72 146 169 190 195 120 99 175
2025/20262.223 373 276 296 658 486 134 0 0 0 0 0 0
Totale 4.874